Say No To Trading
Public Markets Investor, Opportunistic Buying & Cost-Basis Management
UnitedHealth's insurance model beats hospital operators like HCA because insurers get paid while hospitals see a good chunk of bills never paid or heavily reduced. Members must pay premiums to keep their benefits, and insurers don't pay claims until any deductible is met. That makes UnitedHealth attractive and HCA, along with the REITs that own hospitals, unattractive. x.comÂ
Healthcare is the clearest place money is moving, and UnitedHealth is the preferred name here. It beat earnings and raised its 2026 profit forecast. x.comÂ
UnitedHealth's earnings visibility, unusually high dividend yield and resumed buybacks make paying under 16x forward earnings not look terrible. Still reasonably confident it is a good place to hide for long-term capital: Hemsley keeps clearing the bar, and UnitedHealth has beaten and raised guidance for three straight quarters. Further derisking remains a risk. x.com x.com x.comÂ
UnitedHealth's model is a conflict of interest, since it owns both the insurer and the doctors and data, which makes it too dark to own. It has been accused of using algorithms to systematically deny care to the elderly and sick to lift profits; as both the largest US employer of doctors and an insurer, the patient loses. The assassination of its CEO showed deep hostility toward that system. A moat built on denying care is not worth owning. x.comÂ
UnitedHealth remains essential to the US economy and still provides the best pay-and-collect mechanism for doctors and hospitals in the country. Per CNBC, its first-quarter adjusted EPS of $7.23 beat expectations of $6.57, and it raised its full-year earnings outlook. x.comÂ
UnitedHealth's collapse was driven more by fear than fundamentals, making it one of the biggest opportunities in years, reminiscent of Meta in 2022. Fraud accusations led nowhere as the DOJ dropped its investigation, and peers Humana and CVS recovered from the same cost underestimation and beat later. With over $420B in revenue and deep ties to US employers, UnitedHealth is too big to fail and could survive even a fine. That same logic pointed to Berkshire being the undisclosed buyer. x.comÂ
UnitedHealth's rebound still has a Medicaid problem because care costs are outpacing state funding. Q3 operating profit rose to $6.6bn from $4.3bn a year earlier, but Medicaid is still expected to lose money in 2026. x.comÂ
UnitedHealth collects ever-rising US healthcare spending, and its stock has stopped falling. Family plan costs rose 249% in two decades toward $24,000, US spending nears $10,000 a person, and the over-65 population is set to double to two billion by 2050. After earnings fell 59% and 69% in back-to-back quarters and the stock dropped from 606 to 248, it based near 250 for a year, a Weinstein Stage 1, then reclaimed its moving average and pushed above 400. x.com x.com x.com x.comÂ
Managed-care insurance cash flows usually care less about AI bond yields than leveraged hyperscaler debt, making a managed-care sleeve preferable to chasing an AI bounce. UnitedHealth rose about 2.8% alongside Eli Lilly and Walmart after Deutsche Bank upgrades, while semiconductors weakened. x.comÂ
UnitedHealth's debt has to come down to a manageable $20-30B, which would also cut interest expense, and the institutions, TV contributors and big retail accounts pumping it like the next Nvidia are ignoring that. Health insurance is not going away, but the numbers matter more than the hype. x.comÂ
UnitedHealth could be a $600 stock over the next three to five years if margins stabilize, a solid return from here, as the market remembers why it has been a strong long-term compounder. It has scale, Optum, insurance exposure and durable cash flow; the stock was hit by medical-cost pressure, regulation and sentiment, but the business still generates a lot of cash. SoFi and ServiceNow offer more upside, with three-year targets of $80+ and $300+. x.com x.comÂ
